Guide
Botanical Sustainability for Dietary Supplements: FairWild, UEBT, CITES and Supply Chain Due Diligence
Roughly two-thirds of medicinal and aromatic plants on the global market are wild-harvested rather than cultivated. Many face documented over-harvesting pressure — TRAFFIC and IUCN Medicinal Plant Specialist Group assessments place hundreds of supplement-relevant species on threatened or near-threatened lists. The CITES (Convention on International Trade in Endangered Species) Appendices regulate trade in over 35,000 species including several heavily used supplement actives. Beyond regulatory exposure, brand-owners face material reputational risk from consumer advocacy, retailer due-diligence questionnaires, and ESG reporting frameworks (CSRD in the EU from 2024-2026, SEC climate disclosure rules in the US). This guide maps the FairWild Standard, UEBT certification, CITES compliance, the wild-harvest vs cultivated decision, and the supply chain due diligence dossier that defensible botanical sourcing programmes maintain.
Start free trial Free trial, no credit card, onboard in days, not months.
The wild-harvest reality — scale, pressure and the data gap
Wild-harvested medicinal and aromatic plants (MAPs) supply a majority of the global botanical supplement market by ingredient volume — including several high-volume actives (echinacea root from wild populations in some sources, saw palmetto from Florida wild palms, ashwagandha from a mix of wild and cultivated sources, cordyceps from wild collection in some grades, and dozens of regional botanicals from Eastern European, Mediterranean, Andean, African and Asian wild collection). TRAFFIC, IUCN and the Botanic Gardens Conservation International assessments document over-harvesting pressure on hundreds of MAP species, with population declines, range contraction and ecosystem impact. The supply chain visibility is typically poor — wild collection happens at the collector household or village level, passes through aggregators and processors before reaching an ingredient supplier, and the brand-owner sees only the supplier of the processed extract. The data gap is the structural barrier to sustainability assurance: without supply chain visibility back to the collection site, the brand-owner cannot demonstrate sustainable sourcing.
FairWild Standard — the sustainability certification for wild collection
The FairWild Standard, governed by the FairWild Foundation, is the leading sustainability certification specifically for wild-harvested plants. The standard combines ecological criteria (resource assessment, population monitoring, harvest quota setting, harvesting practice impact assessment, regeneration verification), social and fair-trade criteria (fair pricing to collectors, premium fund for community development, child labour and forced labour prohibition, indigenous and traditional knowledge protection, gender equality), and chain-of-custody verification (segregation of certified material, traceability from collector through aggregation and processing to finished ingredient). Certified suppliers are audited by accredited bodies (IMO, Ecocert, Control Union, BIO.INSPECTA among others). The standard aligns with CITES, the Convention on Biological Diversity (CBD) and the Nagoya Protocol on Access and Benefit-Sharing. Adoption is uneven by ingredient — well-established for some flagship botanicals (frankincense, baobab, devil's claw, juniper) but still limited as a share of total wild-collection volume. The FairWild label is consumer-facing where applied to retail product and is increasingly required by sustainability-positioned brands and natural-channel retailers.
UEBT — the broader Ethical BioTrade certification framework
The Union for Ethical BioTrade (UEBT) operates a certification framework covering both wild-collected and cultivated botanical and natural ingredients, with broader scope than FairWild including beauty and food applications alongside supplements. UEBT requires member companies to apply the UEBT Ethical Sourcing System across their natural-ingredient supply chains, with progressive implementation of sourcing practices aligned with the CBD and Nagoya Protocol. Certification is available at the ingredient level (Sourcing with Respect — verifying that a specific ingredient supply chain meets UEBT criteria) and at the company level (UEBT member status indicating organisation-wide commitment). UEBT also operates joint programmes with Rainforest Alliance and Union for Ethical BioTrade/Rainforest Alliance Herbs and Spices for the food and supplement herb categories. The UEBT framework is particularly relevant for brand-owners building ESG and biodiversity disclosure programmes — UEBT membership and certification map cleanly to the biodiversity and supply chain due diligence requirements under CSRD and emerging biodiversity disclosure standards (TNFD — Taskforce on Nature-related Financial Disclosures).
CITES — the trade regulation backstop
The Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), in force since 1975 with 184 Party countries, regulates international trade in over 35,000 species through three Appendices. Appendix I — species threatened with extinction; commercial trade essentially prohibited (Aquilaria spp. for some agarwood grades historically, Hoodia spp., several orchid genera). Appendix II — species not necessarily threatened but where trade must be controlled to avoid uncompatible utilisation; requires CITES export permit from the source country and (for some species) import permit in the destination (Aquilaria spp. for current trade, Cistanche deserticola, Hoodia spp., Pterocarpus santalinus — red sandalwood, several Cycad species, multiple orchid and cactus genera). Appendix III — species protected by at least one country with cooperation from others; requires certificate of origin or export permit. CITES-relevant supplement ingredients include several botanicals (cistanche, hoodia, red sandalwood, agarwood) and animal-derived ingredients (some musk, deer antler from CITES-listed species, certain coral and shell products in TCM contexts). CITES compliance is enforced by customs authorities — non-compliant shipments are seized, with retrospective penalty exposure. Brand-owners using CITES-listed species need permit verification at import and a documented chain of custody to the source population.
Supply chain due diligence — the dossier and the operating posture
Defensible botanical sustainability programmes maintain a per-ingredient supply chain due diligence dossier: (1) species identification to scientific name with chemotype where relevant, IUCN Red List status, CITES Appendix status, national protection status in source countries; (2) source classification — wild-harvested, semi-cultivated, fully cultivated, with the source country, region and population for wild-harvested; (3) supply chain map — collector or grower, aggregator, processor, exporter, supplier, with documented traceability at each tier; (4) certification status — FairWild, UEBT, Fair for Life, organic, demeter, regional schemes; (5) Nagoya Protocol Access and Benefit-Sharing assessment for ingredients sourced from CBD-Party countries with ABS legislation, including the Internationally Recognised Certificate of Compliance where applicable; (6) ESG and CSRD reporting alignment — biodiversity impact assessment, supply chain due diligence per the EU Corporate Sustainability Due Diligence Directive (CSDDD), TNFD-aligned biodiversity disclosure where reporting; (7) risk register — population sustainability risk, regulatory risk (CITES uplisting, national export bans, Nagoya Protocol enforcement), reputational risk (consumer advocacy attention, retailer due diligence demands). The dossier is the basis for procurement decisions, ingredient swap-readiness when a source becomes constrained, and the ESG narrative.
Standards covered in this guide
Each standard, retailer code or assurance scheme referenced above has its own deep-dive page with scope, audit detail and common pitfalls.
Where this lives in V5 Ultimate
The clauses above aren't theoretical — every one maps to a shipped module and an industry profile. Jump to the parts of the product that turn this guide into evidence on a Monday morning.
Modules that do the work
Industries this hits hardest
Frequently asked
Is wild-harvested or cultivated better for sustainability?
It depends. For species with well-managed wild populations and viable sustainable harvest under FairWild-style management, wild collection supports rural livelihoods and ecosystem stewardship and is often the better choice. For species with declining populations, fragile habitats or limited collector capacity, cultivation transition is the only viable long-term path. The decision must be made per species, per region and per ingredient grade, informed by population assessment and supply chain capacity. A blanket preference for either is not defensible; the dossier-based per-ingredient assessment is.
Do we need FairWild certification for our botanical ingredients?
FairWild is not legally mandatory in any jurisdiction. It is increasingly required by sustainability-positioned brands and natural-channel retailers, and it materially supports ESG and biodiversity disclosure narratives. Where the ingredient supply chain is wild-collected and the brand or destination channel demands sustainability assurance, FairWild is the most credible certification available. For cultivated or semi-cultivated ingredients, UEBT, organic certification, Fair for Life or regional schemes may be more appropriate. The choice is driven by the supply chain reality and the destination channel requirements.
What is the Nagoya Protocol and does it affect supplement ingredients?
The Nagoya Protocol on Access and Benefit-Sharing (ABS) is a supplementary agreement to the Convention on Biological Diversity, in force since 2014, requiring that users of genetic resources from a provider country obtain Prior Informed Consent and establish Mutually Agreed Terms covering benefit sharing. The EU ABS Regulation (511/2014) implements the Protocol for the EU and applies to ingredients sourced from CBD-Party countries with ABS legislation (Brazil, India, Peru, South Africa, Vietnam, several others). Supplement ingredients newly developed from genetic resources from these countries — particularly novel botanicals, fermentation organisms isolated from biodiversity hotspots, and traditional knowledge-derived ingredients — are within scope. Non-compliance with the EU regulation triggers enforcement under the EU member state authorities.
How does CSRD affect supplement brand-owners?
The EU Corporate Sustainability Reporting Directive (CSRD), phased in from 2024-2028 by company size, requires reporting against the European Sustainability Reporting Standards (ESRS) including biodiversity and supply chain due diligence elements relevant to botanical sourcing. Brand-owners selling into the EU above the CSRD scope thresholds — and increasingly their suppliers in the value chain — face structured disclosure on biodiversity impact, value chain due diligence, and material sustainability matters. The botanical sustainability dossier becomes the input to ESRS E4 (Biodiversity and Ecosystems) and G1 (Business Conduct) disclosures. The CSDDD (Corporate Sustainability Due Diligence Directive) adds substantive due diligence obligations on top.
See it on your shop floor.
Free trial, no credit card, onboard in days, not months.
Related reading
- 10 CFR 35 medical use readiness — NRC licensing for radiopharmaceuticals
- 21 CFR 111 Readiness: Dietary Supplement cGMP Subparts E & F
- 21 CFR 211 Drug cGMP Readiness Guide
- 21 CFR 212 PET drug cGMP readiness — FDA inspection playbook
- 21 CFR 589 BSE / Ruminant Feed Ban Readiness Guide
- 21 CFR 820 to ISO 13485 Mapping Guide (Including QMSR Harmonisation)
Spot something off? .